Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.
about
Polymer-drug conjugates: origins, progress to date and future directionsDevelopment of macromolecular prodrug for rheumatoid arthritisPharmacokinetic and biodistribution studies of N-(2-hydroxypropyl)methacrylamide copolymer-dexamethasone conjugates in adjuvant-induced arthritis rat model.Intracellular trafficking and subcellular distribution of a large array of HPMA copolymers.Fatty acid substituted polyvinyl alcohol as a supporting material for microsphere preparation.Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers.Combination cytotoxicity of backbone degradable HPMA copolymer gemcitabine and platinum conjugates toward human ovarian carcinoma cellsHPMA copolymers: origins, early developments, present, and future.Biodistribution of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer drug delivery.Tailoring polymersome bilayer permeability improves enhanced permeability and retention effect for bioimaging.Design, synthesis, and biological evaluation of a robust, biodegradable dendrimer.Polysaccharide-modified synthetic polymeric biomaterials.The influence of linker length on the properties of cathepsin S cleavable (177)Lu-labeled HPMA copolymers for pancreatic cancer imagingMacromolecular therapeuticsSequential combination therapy of ovarian cancer with degradable N-(2-hydroxypropyl)methacrylamide copolymer paclitaxel and gemcitabine conjugates.In situ-gelling, erodible N-isopropylacrylamide copolymersImproving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domainSemitelechelic HPMA copolymers functionalized with triphenylphosphonium as drug carriers for membrane transduction and mitochondrial localization.Synthesis of long-circulating, backbone degradable HPMA copolymer-doxorubicin conjugates and evaluation of molecular-weight-dependent antitumor efficacyBiological rationale for the design of polymeric anti-cancer nanomedicines.POLYMERIC BIOMATERIALS AND NANOMEDICINES.Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.Enhanced antitumor activity of combinations of free and HPMA copolymer-bound drugsPolymer conjugates as anticancer nanomedicines.Synthesis and evaluation of a backbone biodegradable multiblock HPMA copolymer nanocarrier for the systemic delivery of paclitaxel.ATRP in the design of functional materials for biomedical applicationsNanostructured materials for applications in drug delivery and tissue engineering.177Lu-labeled HPMA copolymers utilizing cathepsin B and S cleavable linkers: synthesis, characterization and preliminary in vivo investigation in a pancreatic cancer model.Efficiency of high molecular weight backbone degradable HPMA copolymer-prostaglandin E1 conjugate in promotion of bone formation in ovariectomized rats.Combination chemotherapy and photodynamic therapy with fab' fragment targeted HPMA copolymer conjugates in human ovarian carcinoma cellsPoly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery.Tumor-targeted HPMA copolymer-(RGDfK)-(CHX-A''-DTPA) conjugates show increased kidney accumulationHPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluationNoninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.Synergistic enhancement of cancer therapy using a combination of heat shock protein targeted HPMA copolymer-drug conjugates and gold nanorod induced hyperthermia.Beyond oncology--application of HPMA copolymers in non-cancerous diseases.Cellular uptake of functional nanogels prepared by inverse miniemulsion ATRP with encapsulated proteins, carbohydrates, and gold nanoparticles.Diverse Applications of Nanomedicine.RAFT polymerization and thiol chemistry: a complementary pairing for implementing modern macromolecular design.Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
P2860
Q27002505-D08D77BC-B218-450B-B081-C4BDAA7FC216Q27693332-FEDEDA0E-C902-4A65-A0F8-0EE9189C5685Q30495832-E177E93B-0300-4564-B9BF-73AB1A8EBD4DQ30502459-480F78E0-4FBF-401A-A081-C7447E639C2BQ32000370-3B459BD5-1CFE-4D81-8628-A378A63A5930Q33235069-FACE418F-B6B3-454E-9EB8-3C56BDDBDF15Q33670961-9A5DC6FB-2B2B-48FD-A95A-BFD827D40AA3Q33719148-739C98D1-B3F6-4C94-8C90-546AE215CA81Q33836864-8D00EA60-716C-43A2-BFB8-849DE8FADBF1Q33893586-0CA2D0B8-5E90-4534-9FA1-2727F46E2AF5Q33910306-4B5E752E-D47A-4CB1-96E0-36F3C015DF58Q33978402-8271EDA3-D6A4-4AF4-B9B6-6645BBBD3609Q33981400-046A8B1C-8BD3-46F9-9D53-0EF7954386A8Q34079574-B28439A8-0F8B-408E-9582-25CCD1BC76A5Q34082844-5724126E-6680-41D4-BAA6-73F72877CD6BQ34345022-ABD58668-23C6-4BA2-9648-3D4954D3C2D1Q34724092-B2DC994E-74CE-49C2-ADAC-B43A1B63EEBCQ35104672-3737142A-F367-4EF2-8F72-E34E9887FC14Q36126612-EE616676-2B59-47F1-91B9-B9D8E48C0F2DQ36160333-D5F66BD2-FFA3-4823-BD58-416D03856257Q36376467-ADCF90BA-67BE-40EB-A3A4-0DDDF61264F6Q36465829-0502FFED-CBC2-4B71-985B-900067C7D6EBQ36502354-3071B582-76C7-4DC5-AB7F-E39353E1AF32Q36561667-CE14A870-4F6F-4F7E-B797-23A638E1CDDEQ36589127-0EA0A2B0-F156-4291-BCCF-DF1AC89E6B94Q36706919-66C93B0B-7C4C-4FAD-AD17-9937BBB3D7D1Q36807625-D37D8697-8188-45FF-9D8C-8DBA99B7F5B5Q36881050-86C42208-D693-494E-88D6-9894DA511584Q36940281-65E7C2A6-4CC2-4C4F-9CC8-FBCBD6E2BC72Q37107517-0D7876A0-CDC0-4163-B0E7-B410F7060E46Q37121790-5DE4D20F-DCAC-4203-88E6-5FD66D478D45Q37226124-2BA20669-55E5-4F4E-9175-CBEEDEE00477Q37246034-ECD584BF-1EEA-4C64-B9C0-A97C666111E1Q37325981-835A6242-705D-4D78-8B1A-671F3E025462Q37386314-71BC0BE7-A1C7-46B7-B07D-65878DF1691DQ37631869-FAA0F620-B861-4E0B-8E90-8020BD73F014Q37639084-9551A94E-7A20-4A3B-9E20-E87FBB892CF5Q37728142-08F32D2B-C701-4496-86BF-EB294E9E7225Q37875014-3E349463-52C6-45E4-BA3F-C5B8593E4868Q38095361-02735E1D-437E-49BE-A922-D22B1FA6ACF7
P2860
Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
Effect of molecular weight (Mw ...... venous administration to rats.
@en
Effect of molecular weight (Mw ...... venous administration to rats.
@nl
type
label
Effect of molecular weight (Mw ...... venous administration to rats.
@en
Effect of molecular weight (Mw ...... venous administration to rats.
@nl
prefLabel
Effect of molecular weight (Mw ...... venous administration to rats.
@en
Effect of molecular weight (Mw ...... venous administration to rats.
@nl
P2093
P356
P1476
Effect of molecular weight (Mw ...... avenous administration to rats
@en
P2093
P2860
P304
P356
10.1002/JBM.820211106
P50
P577
1987-11-01T00:00:00Z